RXRX Award Disclosure
Hassan Fred · SEC Form 4 · Filed Nov 4, 2026
Award
Calculated transaction value
$0
Hassan Fred Director
RXRX
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
RXRX daily price context
Close on/before transaction
$3.83
Nov 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 156,658 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001601830-26-000151
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Award | Nov 2, 2026 | $0 |